PuSH - Publication Server of Helmholtz Zentrum München: Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.

Navigation

Research

Browse by ...

... Journal

Support & Contact

Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.

Onkologie 14, 31-34 (1991)

Open Access Green as soon as Postprint is submitted to ZB.

Altmetric

Additional Metrics?

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

ISSN (print) / ISBN 0378-584X

e-ISSN 1423-0240

Journal Onkologie

Quellenangaben Volume: 14, Issue: 1, Pages: 31-34

Publisher Karger

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institut für Klinische Hämatologie